SLC8A1 and Stroke: Recent studies examined miR-103-1 as a treatment strategy for stroke, based on its potential to regulate the expression of the Na+/Ca2+ exchanger (NCX1), which mediates bidirectional flux of calcium and sodium across the synaptic membrane and increases ischemic damage in rat brain (111).